Association of red blood cell n-3 polyunsaturated fatty acids with plasma inflammatory biomarkers among the Quebec Cree population

European Journal of Clinical Nutrition

Volumn 68, Issue 9, 2014, Pages 1042-1047

  Labonte M E ^a   Dewailly, E ^a,b   Lucas, M ^a,b   Couture, P ^a   Lamarche, B ^a  

^a UNIVERSITÉ LAVAL   (Canada)

^b LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; DOCOSAPENTAENOIC ACID; INTERLEUKIN 6; OMEGA 3 FATTY ACID; TUMOR NECROSIS FACTOR; BIOLOGICAL MARKER; DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; TUMOR NECROSIS FACTOR ALPHA; UNSATURATED FATTY ACID;

ADULT; AGED; ARTICLE; CREE (PEOPLE); DIETARY INTAKE; ERYTHROCYTE; FEMALE; HUMAN; HUMAN CELL; INFLAMMATION; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PROTEIN BLOOD LEVEL; QUEBEC; RISK ASSESSMENT; SEX DIFFERENCE; SOCIAL STATUS; SYSTEMIC DISEASE; WAIST CIRCUMFERENCE; AMERICAN INDIAN; BLOOD; CANADA; CROSS-SECTIONAL STUDY; METABOLISM; PREVALENCE;

ADULT; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CROSS-SECTIONAL STUDIES; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; ERYTHROCYTES; FATTY ACIDS, OMEGA-3; FATTY ACIDS, UNSATURATED; FEMALE; HUMANS; INDIANS, NORTH AMERICAN; INFLAMMATION; INTERLEUKIN-6; MALE; PREVALENCE; QUEBEC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84929049084     PISSN: 09543007     EISSN: 14765640     Source Type: Journal    
DOI: 10.1038/ejcn.2014.125     Document Type: Article

References (42)

1. Haman F, Fontaine-Bisson B, Batal M, Imbeault P, Blais JM, Robidoux MA. Obesity and type 2 diabetes in Northern Canada's remote First Nations communities: the dietary dilemma. Int J Obes (Lond) 2010; 34(Suppl 2): S24-S31.
2. Garriguet D. Obesity and the eating habits of the Aboriginal population. Health Rep 2008; 19: 21-35.
3. Dannenbaum D, Kuzmina E, Lejeune P, Torrie J, Gangbe M. Prevalence of diabetes and diabetes-related complications in First Nations communities in northern Quebec (Eeyou Istchee), Canada. Can J Diabetes 2008; 32: 46-52.
4. Shah BR, Hux JE, Zinman B. Increasing rates of ischemic heart disease in the native population of Ontario, Canada. Arch Intern Med 2000; 160: 1862-1866.
5. Young TK, Reading J, Elias B, O'Neil JD. Type 2 diabetes mellitus in Canada's first nations: status of an epidemic in progress. CMAJ 2000; 163: 561-566.
6. Scrivo R, Vasile M, Bartosiewicz I, Valesini G. Inflammation as 'common soil' of the multifactorial diseases. Autoimmun Rev 2011; 10: 369-374.
7. Connelly PW, Hanley AJ, Harris SB, Hegele RA, Zinman B. Relation of waist circumference and glycemic status to C-reactive protein in the Sandy Lake Oji-Cree. Int J Obes (Lond) 2003; 27: 347-354.
8. Anand SS, Razak F, Yi QL, Davis B, Jacobs R, Vuksan V et al. C-reactive protein as a screening test for cardiovascular risk in a multiethnic population. Arterioscler Thromb Vasc Biol 2004; 24: 1509-1515.
9. Imbeault P, Findlay CS, Robidoux MA, Haman F, Blais JM, Tremblay A et al. Dysregulation of cytokine response in Canadian First Nations communities: is there an association with persistent organic pollutant levels? PLoS One 2012; 7: e39931.
10. Liu J, Young TK, Zinman B, Harris SB, Connelly PW, Hanley AJ. Lifestyle variables, non-traditional cardiovascular risk factors, and the metabolic syndrome in an Aboriginal Canadian population. Obesity (Silver Spring) 2006; 14: 500-508.
11. Lopez-Garcia E, Schulze MB, Manson JE, Meigs JB, Albert CM, Rifai N et al. Consumption of (n-3) fatty acids is related to plasma biomarkers of inflammation and endothelial activation in women. J Nutr 2004; 134: 1806-1811.
12. Zampelas A, Panagiotakos DB, Pitsavos C, Das UN, Chrysohoou C, Skoumas Y et al. Fish consumption among healthy adults is associated with decreased levels of inflammatory markers related to cardiovascular disease: the ATTICA study. J Am Coll Cardiol 2005; 46: 120-124.
13. He K, Liu K, Daviglus ML, Jenny NS, Mayer-Davis E, Jiang R et al. Associations of dietary long-chain n-3 polyunsaturated fatty acids and fish with biomarkers of inflammation and endothelial activation (from the Multi-Ethnic Study of Atherosclerosis [MESA]). Am J Cardiol 2009; 103: 1238-1243.
14. Micallef MA, Munro IA, Garg ML. An inverse relationship between plasma n-3 fatty acids and C-reactive protein in healthy individuals. Eur J Clin Nutr 2009; 63: 1154-1156.
15. Farzaneh-Far R, Harris WS, Garg S, Na B, Whooley MA. Inverse association of erythrocyte n-3 fatty acid levels with inflammatory biomarkers in patients with stable coronary artery disease: The Heart and Soul Study. Atherosclerosis 2009; 205: 538-543.
16. Reinders I, Virtanen JK, Brouwer IA, Tuomainen TP. Association of serum n-3 polyunsaturated fatty acids with C-reactive protein in men. Eur J Clin Nutr 2012; 66: 736-741.
17. Kalogeropoulos N, Panagiotakos DB, Pitsavos C, Chrysohoou C, Rousinou G, Toutouza M et al. Unsaturated fatty acids are inversely associated and n-6/n-3 ratios are positively related to inflammation and coagulation markers in plasma of apparently healthy adults. Clin Chim Acta 2010; 411: 584-591.
18. Mozaffarian D, Lemaitre RN, King IB, Song X, Spiegelman D, Sacks FM et al. Circulating long-chain omega-3 fatty acids and incidence of congestive heart failure in older adults: the cardiovascular health study: a cohort study. Ann Intern Med 2011; 155: 160-170.
19. Ferrucci L, Cherubini A, Bandinelli S, Bartali B, Corsi A, Lauretani F et al. Relationship of plasma polyunsaturated fatty acids to circulating inflammatory markers. J Clin Endocrinol Metab 2006; 91: 439-446.
20. Makhoul Z, Kristal AR, Gulati R, Luick B, Bersamin A, Boyer B et al. Associations of very high intakes of eicosapentaenoic and docosahexaenoic acids with biomarkers of chronic disease risk among Yup'ik Eskimos. Am J Clin Nutr 2010; 91: 777-785.
21. Makhoul Z, Kristal AR, Gulati R, Luick B, Bersamin A, O'Brien D et al. Associations of obesity with triglycerides and C-reactive protein are attenuated in adults with high red blood cell eicosapentaenoic and docosahexaenoic acids. Eur J Clin Nutr 2011; 65: 808-817.
22. Dewailly E, Blanchet C, Gingras S, Lemieux S, Holub BJ. Cardiovascular disease risk factors and n-3 fatty acid status in the adult population of James Bay Cree. Am J Clin Nutr 2002; 76: 85-92.
23. Dewailly E, Blanchet C, Gingras S, Lemieux S, Holub BJ. Fish consumption and blood lipids in three ethnic groups of Quebec (Canada). Lipids 2003; 38: 359-365.
24. Sun Q, Ma J, Campos H, Hankinson SE, Hu FB. Comparison between plasma and erythrocyte fatty acid content as biomarkers of fatty acid intake in US women. Am J Clin Nutr 2007; 86: 74-81.
25. Vidgren HM, Agren JJ, Schwab U, Rissanen T, Hanninen O, Uusitupa MI. Incorporation of n-3 fatty acids into plasma lipid fractions, and erythrocyte membranes and platelets during dietary supplementation with fish, fish oil, and docosahexaenoic acid-rich oil among healthy young men. Lipids 1997; 32: 697-705.
26. Katan MB, Deslypere JP, van Birgelen AP, Penders M, Zegwaard M. Kinetics of the incorporation of dietary fatty acids into serum cholesteryl esters, erythrocyte membranes, and adipose tissue: an 18-month controlled study. J Lipid Res 1997; 38: 2012-2022.
27. Valera B, Dewailly E, Poirier P. Impact of mercury exposure on blood pressure and cardiac autonomic activity among Cree adults (James Bay, Quebec, Canada). Environ Res 2011; 111: 1265-1270.
28. Ridker PM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 2003; 107: 363-369.
29. Nieboer E, Dewailly E, Egeland GM, Château-Degat M-L, Bonnier-Viger Y. Nituuchischaayihtitaau Aschii. Multi-Community Environment-and-Health Longitudinal Study in Eeyou Istchee: Eastmain and Wemindji. Technical report: summary of 2007 activities, results and recommendations. In:Nieboer E, Robinson E, Petrov K (eds). Public Health Report Series 4 on the Health of the Population. Cree Board of Health and Social Services of James Bay: Chisasibi, QC, Canada, 2011.
30. Alberti KGMM, Zimmet P, Shaw J. The metabolic syndrome - a new worldwide definition. Lancet 2005; 366: 1059-1062.
31. Pirro M, Bergeron J, Dagenais GR, Bernard PM, Cantin B, Despres JP et al. Age and duration of follow-up as modulators of the risk for ischemic heart disease associated with high plasma C-reactive protein levels in men. Arch Intern Med 2001; 161: 2474-2480.
32. Sampasa-Kanyinga H, Levesque B, Anassour-Laouan-Sidi E, Cote S, Serhir B, Ward BJ et al. Zoonotic infections in native communities of James Bay, Canada. Vector Borne Zoonotic Dis 2012; 12: 473-481.
33. International Physical Activity Questionnaire (IPAQ). Guidelines for Data Processing and Analysis of the International Physical Activity Questionnaire (IPAQ) - Short and Long Forms November 2005. Available from http://www.ipaq.ki.se/scoring.pdf (accessed 23 July 2013).
34. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO, Criqui M et al. Markers of inflammation and cardiovascular disease application to clinical and public health practice - A statement for healthcare professionals from the centers for disease control and prevention and the American Heart Association. Circulation 2003; 107: 499-511.
35. Labonte ME, Dewailly E, Chateau-Degat ML, Couture P, Lamarche B. Population-based study of high plasma C-reactive protein concentrations among the Inuit of Nunavik. Int J Circumpolar Health 2012; 71: 19066.
36. Bruunsgaard H, Pedersen M, Pedersen BK. Aging and proinflammatory cytokines. Curr Opin Hematol 2001; 8: 131-136.
37. Sun Q, Ma J, Campos H, Rexrode KM, Albert CM, Mozaffarian D et al. Blood concentrations of individual long-chain n-3 fatty acids and risk of nonfatal myocardial infarction. Am J Clin Nutr 2008; 88: 216-223.
38. Rowley K, Walker KZ, Cohen J, Jenkins AJ, O'Neal D, Su Q et al. Inflammation and vascular endothelial activation in an Aboriginal population: relationships to coronary disease risk factors and nutritional markers. Med J Aust 2003; 178: 495-500.
39. Mozaffarian D, Wu JH. (n-3) fatty acids and cardiovascular health: are effects of EPA and DHA shared or complementary? J Nutr 2012; 142: 614S-625S.
40. Kaur G, Cameron-Smith D, Garg M, Sinclair AJ. Docosapentaenoic acid (22:5n-3): a review of its biological effects. Prog Lipid Res 2011; 50: 28-34.
41. Borgeson E, Godson C. Resolution of inflammation: therapeutic potential of pro-resolving lipids in type 2 diabetes mellitus and associated renal complications. Front Immunol 2012; 3: 318.
42. Potischman N. Biologic and methodologic issues for nutritional biomarkers. J Nutr 2003; 133(Suppl 3): 875S-880S.